|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/436 | |
| A61K 9/10 | |||
| A61K 9/107 | |||
| A61P 27/02 | |||
| A61K 31/675 |
| (11) | Number of the document | 2974728 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14763999.1 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2014/056416 |
| Date | 2014-03-12 |
| (87) | Number | WO 2014/142146 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 2013050766 | 2013-03-13 | JP |
| (72) |
MIYAKE, Hideki, JP
ODA, Tomoko, JP
SHII, Daisuke, JP
|
| (73) |
Santen Pharmaceutical Co., Ltd,
9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka-shi Osaka 533-8651,
JP
|
| (54) | THERAPEUTIC AGENT FOR MEIBOMIAN DYSFUNCTION |
| THERAPEUTIC AGENT FOR MEIBOMIAN DYSFUNCTION |